USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
RECOMBINETICS, INC.
Address:
1246 University Ave. W
ST PAUL, MN 55104-
Phone:
N/A
URL:
N/A
EIN:
126312147
DUNS:
829874523
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $232,864.00 1
STTR Phase I $318,202.00 1

Award List:

Development of Porcine Genetic Models of Atherosclerosis

Award Year / Program / Phase:
2011 / STTR / Phase I
Award Amount:
$318,202.00
Agency:
HHS
Principal Investigator:
Scott C. Fahrenkrug – 612-670-2078
Research Institution:
UNIVERSITY OF MINNESOTA
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Because the cardiovascular anatomy of swine is similar to humans with regard to size, morphology, relative collateral arterial supply, and the presence of a well-developed vasa vasorum, the porcine coronary arterial model is the standard for the preclinical… More

Artiodactyl Gene Modification with Tal Effector Nucleases

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$232,864.00
Agency:
HHS
Principal Investigator:
Scott C. Fahrenkrug – 612-670-2078
Abstract:
DESCRIPTION (provided by applicant): Large animal models of human disease are indispensible for the development of relevant preclinical therapeutic protocols. Gene inactivation and gene conversion are powerful approaches for creating genocopies of allelesthat cause disease in patients and for the… More